Under pathophysiological conditions, endothelin-1 shows vasoconstrictor, mitogenic, pro-inflammatory, and pro-thrombotic effects, and its excessive secretion contributes to the development of cardiovascular diseases such as: atherosclerosis, arterial and pulmonary hypertension, heart failure, and diabetes [17]. Here, EDN1 is linked to atherosclerosis.